Abdelazaher et al. [14] reported that overexpression of Her2 was associated with shorter RFS of WHO grade I meningioma patients using univariate Cox regression analysis (HR = 1.533, 95%CI 1.027 to 2.29). This evidence concerns the gene ERBB2 and meningioma.